New insights regarding tissue Se and Hg interactions on oxidative stress from plasma IsoP and IsoF measures in the Canadian Inuit population

Journal of Lipid Research

Volumn 54, Issue 7, 2013, Pages 1972-1979

  Alkazemi, Dalal ^a,b   Egeland, Grace M ^b,c   Roberts II, L Jackson ^d   Chan, Hing M ^e   Kubow, Stan ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF BERGEN   (Norway)

^d VANDERBILT UNIVERSITY   (United States)

^e UNIVERSITY OF OTTAWA   (Canada)

Author keywords

C reactive protein; Isofuran; Isoprostane; Mercury; Selenium

Indexed keywords

FURAN DERIVATIVE; ISOFURAN; ISOPROSTANE DERIVATIVE; METHYLMERCURY; SELENIUM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CANADA; CARDIOVASCULAR RISK; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; MOLECULAR INTERACTION; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; OXIDATIVE STRESS; PRIORITY JOURNAL; RISK FACTOR; TISSUE LEVEL; WAIST CIRCUMFERENCE;

EID: 84878969486     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M033068     Document Type: Article

References (51)

1. Mozaffarian, D. 2009. Fish, mercury, selenium and cardiovascular risk: current evidence and unanswered questions. Int. J. Environ. Res. Public Health. 6: 1894-1916.
2. Huang, Y. L., S. L. Cheng, and T. H. Lin. 1996. Lipid peroxidation in rats administrated with mercuric chloride. Biol. Trace Elem. Res. 52: 193-206. (Pubitemid 26182194)
3. Chen, C., L. Qu, B. Li, L. Xing, G. Jia, T. Wang, Y. Gao, P. Zhang, M. Li, W. Chen, and Z. Chai. 2005. Increased oxidative DNA damage, as assessed by urinary 8-hydroxy-2′-deoxyguanosine concentrations, and serum redox status in persons exposed to mercury. Clin. Chem. 51: 759-767. (Pubitemid 40463928)
4. Salonen, J. T., K. Seppanen, T. A. Lakka, R. Salonen, and G. A. Kaplan. 2000. Mercury accumulation and accelerated progression of carotid atherosclerosis: a population-based prospective 4-year follow-up study in men in eastern Finland. Atherosclerosis. 148: 265-273. (Pubitemid 30064457)
5. Guallar, E., M. I. Sanz-Gallardo, P. van't Veer, P. Bode, A. Aro, J. Gomez-Aracena, J. D. Kark, R. A. Riemersma, J. M. Martin-Moreno, and F. J. Kok. 2002. Mercury, fish oils, and the risk of myocardial infarction. N. Engl. J. Med. 347: 1747-1754. (Pubitemid 35375613)
6. Yoshizawa, K., E. B. Rimm, J. S. Morris, V. L. Spate, C. C. Hsieh, D. Spiegelman, M. J. Stampfer, and W. C. Willett. 2002. Mercury and the risk of coronary heart disease in men. N. Engl. J. Med. 347: 1755-1760. (Pubitemid 35375614)
7. Choi, A. L., P. Weihe, E. Budtz-Jorgensen, P. J. Jorgensen, J. T. Salonen, T. P. Tuomainen, K. Murata, H. P. Nielsen, M. S. Petersen, J. Askham, et al. 2009. Methylmercury exposure and adverse cardiovascular effects in Faroese whaling men. Environ. Health Perspect. 117: 367-372.
8. Park, K., and D. Mozaffarian. 2010. Omega-3 fatty acids, mercury, and selenium in fish and the risk of cardiovascular diseases. Curr. Atheroscler. Rep. 12: 414-422.
9. Virtanen, J. K., T. H. Rissanen, S. Voutilainen, and T. P. Tuomainen. 2007. Mercury as a risk factor for cardiovascular diseases. J. Nutr. Biochem. 18: 75-85. (Pubitemid 46048990)
10. Gailer, J., G. N. George, I. J. Pickering, S. Madden, R. C. Prince, E. Y. Yu, M. B. Denton, H. S. Younis, and H. V. Aposhian. 2000. Structural basis of the antagonism between inorganic mercury and selenium in mammals. Chem. Res. Toxicol. 13: 1135-1142.
11. Tapiero, H., D. M. Townsend, and K. D. Tew. 2003. The antioxidant role of selenium and seleno-compounds. Biomed. Pharmacother. 57: 134-144. (Pubitemid 36734802)
12. Jin, X., H. M. Chan, E. Lok, K. Kapal, M. Taylor, S. Kubow, and R. Mehta. 2008. Dietary fats modulate methylmercury-mediated systemic oxidative stress and oxidative DNA damage in rats. Food Chem. Toxicol. 46: 1706-1720.
13. Ralston, N. V., J. L. Blackwell 3rd, and L. J. Raymond. 2007. Importance of molar ratios in selenium-dependent protection against methylmercury toxicity. Biol. Trace Elem. Res. 119: 255-268. (Pubitemid 350085249)
14. Ralston, N. V., and L. J. Raymond. 2010. Dietary selenium's protective effects against methylmercury toxicity. Toxicology. 278: 112-123.
15. Yoneda, S., and K. T. Suzuki. 1997. Equimolar Hg-Se complex binds to selenoprotein P. Biochem. Biophys. Res. Commun. 231: 7-11. (Pubitemid 27212099)
16. Dewailly, E., C. Blanchet, S. Lemieux, L. Sauve, S. Gingras, P. Ayotte, and B. J. Holub. 2001. n-3 Fatty acids and cardiovascular disease risk factors among the Inuit of Nunavik. Am. J. Clin. Nutr. 74: 464-473. (Pubitemid 32880256)
17. Bélanger, M. C., E. Dewailly, L. Berthiaume, M. Noel, J. Bergeron, M. E. Mirault, and P. Julien. 2006. Dietary contaminants and oxidative stress in Inuit of Nunavik. Metabolism. 55: 989-995.
18. Bjerregaard, P., T. K. Young, and R. A. Hegele. 2003. Low incidence of cardiovascular disease among the Inuit-what is the evidence? Atherosclerosis. 166: 351-357. (Pubitemid 36071694)
19. Valera, B., E. Dewailly, and P. Poirier. 2008. Cardiac autonomic activity and blood pressure among Nunavik Inuit adults exposed to environmental mercury: a cross-sectional study. Environ. Health. 7: 29.
20. Oka, T., M. Matsukura, M. Okamoto, N. Harada, T. Kitano, T. Miike, and M. Futatsuka. 2002. Autonomic nervous functions in fetal type Minamata disease patients: assessment of heart rate variability. Tohoku J. Exp. Med. 198: 215-221. (Pubitemid 36305126)
21. Grandjean, P., K. Murata, E. Budtz-Jorgensen, and P. Weihe. 2004. Cardiac autonomic activity in methylmercury neurotoxicity: 14-year follow-up of a Faroese birth cohort. J. Pediatr. 144: 169-176. (Pubitemid 38869390)
22. Pedersen, E. B., M. E. Jorgensen, M. B. Pedersen, C. Siggaard, T. B. Sorensen, G. Mulvad, J. C. Hansen, G. Asmund, and H. Skjoldborg. 2005. Relationship between mercury in blood and 24-h ambulatory blood pressure in Greenlanders and Danes. Am. J. Hypertens. 18: 612-618. (Pubitemid 40692428)
23. Bélanger, M. C., M. E. Mirault, E. Dewailly, L. Berthiaume, and P. Julien. 2008. Environmental contaminants and redox status of coenzyme Q10 and vitamin E in Inuit from Nunavik. Metabolism. 57: 927-933. (Pubitemid 351814684)
24. Kadiiska, M. B., B. C. Gladen, D. D. Baird, L. B. Graham, C. E. Parker, B. N. Ames, S. Basu, G. A. Fitzgerald, J. A. Lawson, L. J. Marnett, et al. 2005. Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic. Biol. Med. 38: 711-718. (Pubitemid 40249741)
25. Helmersson, J., J. Arnlov, B. Vessby, A. Larsson, G. Alfthan, and S. Basu. 2005. Serum selenium predicts levels of F2-isoprostanes and prostaglandin F2alpha in a 27 year follow-up study of Swedish men. Free Radic. Res. 39: 763-770. (Pubitemid 40959664)
26. Fessel, J. P., and L. J. Roberts 2nd. 2005. Isofurans: novel products of lipid peroxidation that define the occurrence of oxidant injury in settings of elevated oxygen tension. Antioxid. Redox Signal. 7: 202-209. (Pubitemid 40187937)
27. Alkazemi, D., G. Egeland, L. J. Roberts 2nd, and S. Kubow. 2012. Isoprostanes and isofurans as non-traditional risk factors for cardiovascular disease among Canadian Inuit. Free Radic. Res. 46: 1258-1266.
28. Uno, K., and S. J. Nicholls. 2010. Biomarkers of inflammation and oxidative stress in atherosclerosis. Biomark. Med. 4: 361-373.
29. Saudny, H., D. Leggee, and G. Egeland. 2012. Design and methods of the Adult Inuit Health Survey 2007-2008. Int. J. Circumpolar Health. 71: 19572.
30. Egeland, G. M., Z. Cao, and T. K. Young. 2011. Hypertriglyceridemic-waist phenotype and glucose intolerance among Canadian Inuit: the International Polar Year Inuit Health Survey for Adults 2007-2008. CMAJ. 183: E553-E558.
31. Longnecker, M. P., M. J. Stampfer, J. S. Morris, V. Spate, C. Baskett, M. Mason, and W. C. Willett. 1993. A 1-y trial of the effect of high-selenium bread on selenium concentrations in blood and toenails. Am. J. Clin. Nutr. 57: 408-413. (Pubitemid 23083653)
32. Grundy, S. M., B. S. Hansen, C. C. Sidney, I. James, and R. A. Kahn. 2004. Clinical management of metabolic syndrome. Circulation. 109: 551-556.
33. Milne, G. L., H. Yin, J. D. Brooks, S. Sanchez, L. J. Roberts 2nd, and J. D. Morrow. 2007. Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol. 433: 113-126.
34. Butler Walker, J., J. Houseman, L. Seddon, E. McMullen, K. Tofflemire, C. Mills, A. Corriveau, J. P. Weber, A. LeBlanc, M. Walker, et al. 2006. Maternal and umbilical cord blood levels of mercury, lead, cadmium, and essential trace elements in Arctic Canada. Environ. Res. 100: 295-318. (Pubitemid 43234245)
35. Kingman, A., T. Albertini, and L. J. Brown. 1998. Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population. J. Dent. Res. 77: 461-471. (Pubitemid 32770543)
36. Pollack, A. Z., E. F. Schisterman, L. R. Goldman, S. L. Mumford, N. J. Perkins, M. S. Bloom, C. B. Rudra, R. W. Browne, and J. Wactawski-Wende. 2012. Relation of blood cadmium, lead, and mercury levels to biomarkers of lipid peroxidation in premenopausal women. Am. J. Epidemiol. 175: 645-652.
37. Jin, X., N. Hidiroglou, E. Lok, M. Taylor, K. Kapal, N. Ross, K. Sarafin, A. Lau, A. De Souza, H. Chan, et al. 2012. Dietary selenium (Se) and vitamin E (VE) supplementation modulated methylmercury-mediated changes in markers of cardiovascular diseases in rats. Cardiovasc. Toxicol. 12: 10-24.
38. Khan, M. A., and F. Wang. 2009. Mercury-selenium compounds and their toxicological significance: toward a molecular understanding of the mercury-selenium antagonism. Environ. Toxicol. Chem. 28: 1567-1577.
39. Seppänen, K., M. Kantola, R. Laatikainen, K. Nyyssönen, V. P. Valkonen, V. Kaarlöpp, and J. T. Salonen. 2000. Effect of supplementation with organic selenium on mercury status as measured by mercury in pubic hair. J. Trace Elem. Med. Biol. 14: 84-87. (Pubitemid 30469345)
40. Li, P., X. Feng, G. Qiu, Z. Li, X. Fu, M. Sakamoto, X. Liu, and D. Wang. 2008. Mercury exposures and symptoms in smelting workers of artisanal mercury mines in Wuchuan, Guizhou, China. Environ. Res. 107: 108-114. (Pubitemid 351508243)
41. Houston, M. C. 2011. Role of mercury toxicity in hypertension, cardiovascular disease, and stroke. J. Clin. Hypertens. (Greenwich). 13: 621-627.
42. Lund, B. O., D. M. Miller, and J. S. Woods. 1991. Mercury-induced H2O2 production and lipid peroxidation in vitro in rat kidney mitochondria. Biochem. Pharmacol. 42: S181-S187.
43. Bélanger, M. C., M. E. Mirault, E. Dewailly, M. Plante, L. Berthiaume, M. Noël, and P. Julien. 2008. Seasonal mercury exposure and oxidant- antioxidant status of James Bay sport fishermen. Metabolism. 57: 630-636.
44. Arnér, E. S. J. 2009. Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim. Biophys. Acta. 1790: 495-526.
45. Fontaine, J., E. Dewailly, J. L. Benedetti, D. Pereg, P. Ayotte, and S. Dery. 2008. Re-evaluation of blood mercury, lead and cadmium concentrations in the Inuit population of Nunavik (Quebec): a cross-sectional study. Environ. Health. 7: 25.
46. Alissa, E. M., S. M. Bahijri, and G. A. Ferns. 2003. The controversy surrounding selenium and cardiovascular disease: a review of the evidence. Med. Sci. Monit. 9: RA9-RA18. (Pubitemid 36206927)
47. Kretz-Remy, C., and A. P. Arrigo. 2001. Selenium: a key element that controls NF-kappa B activation and I kappa B alpha half life. Biofactors. 14: 117-125. (Pubitemid 32848306)
48. Maehira, F., I. Miyagi, and Y. Eguchi. 2003. Selenium regulates transcription factor NF-kappa B activation during the acute phase reaction. Clin. Chim. Acta. 334: 163-171. (Pubitemid 36836071)
49. Hong, Y., C. H. Li, J. R. Burgess, M. Chang, A. Salem, K. Srikumar, and C. C. Reddy. 1989. The role of selenium-dependent and selenium-independent glutathione peroxidases in the formation of prostaglandin F2 alpha. J. Biol. Chem. 264: 13793-13800. (Pubitemid 19198472)
50. Valera, B., E. Dewailly, and P. Poirier. 2009. Environmental mercury exposure and blood pressure among Nunavik Inuit adults. Hypertension. 54: 981-986.
51. Nälsén, C., B. Vessby, L. Berglund, M. Uusitupa, K. Hermansen, G. Riccardi, A. Rivellese, L. Storlien, A. Erkkilä, S. Ylä-Herttuala, L. Tapsell, S. Basu. 2006. Dietary (n-3) fatty acids reduce plasma F2-isoprostanes but not prostaglandin F2alpha in healthy humans. J. Nutr. 136: 1222-1228.